What is the main difference between IGF-1 DES and Larazotide Acetate?

IGF-1 DES is primarily classified as a performance compound (truncated igf-1 with localized hypertrophic action; favored for site-specific bodybuilding research.). Larazotide Acetate is a recovery compound (tight-junction regulator developed for celiac disease; reduces intestinal permeability.).

Can IGF-1 DES and Larazotide Acetate be stacked together?

Some peptide pairs in different categories (e.g., recovery + cognitive) are commonly stacked. Others overlap mechanistically and shouldn't be combined. Always consult a licensed physician before stacking compounds.

Side-by-side comparison

IGF-1 DES vs Larazotide Acetate

Truncated IGF-1 with localized hypertrophic action; favored for site-specific bodybuilding research. versus Tight-junction regulator developed for celiac disease; reduces intestinal permeability.

IGF-1 DES

Performance

Truncated IGF-1 with localized hypertrophic action; favored for site-specific bodybuilding research.

Top benefits

✓Localized muscle hyperplasia
✓Stronger receptor binding than wild-type

Full IGF-1 DES guide→

Larazotide Acetate

Recovery

Tight-junction regulator developed for celiac disease; reduces intestinal permeability.

Top benefits

✓Tightens intestinal junctions
✓Reduces leaky-gut markers
✓Studied in celiac disease

Full Larazotide Acetate guide→

Attribute	IGF-1 DES	Larazotide Acetate
Category	Performance	Recovery
Type	protein	linear
Chain length	67 aa	8 aa
Formula	modified IGF-1	C39H56N10O15
Common dose	20–50 mcg	0.5 mg
Frequency	Post-workout	3x daily, oral
Top benefit	Localized muscle hyperplasia	Tightens intestinal junctions
Top side-effect	Hypoglycemia risk	Headache

⚠

Educational use only

This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.